Major plasma products marketed by ZLB Behring
Haemophilia and Other Coagulation Disorders
Coagulation therapies are used to treat bleeding disorders such as haemophilia and Von Willebrand disease
- Recombinant Factor VIII
- Helixate® FS
- Helixate® NexGen
- Plasma-derived Factor VIII
- Beriate® P
- Haemate® P
- Humate-P®
- Monoclate-P®
- Plasma-derived Factor IX
- Berinin® P
- Mononine®
- Factor IX HS
- Von Willebrand Disease
- Haemate® P
- Humate-P®
- Stimate®
- Other Coagulation Disorders
- Beriplex® P
- Fibrogammin® P
- Haemocomplettan® P
- Kybernin® P
Critical Care Conditions
Critical care products are used to treat shock, sepsis and severe burns, and are used in cardiac surgery
- Trauma Therapies
- AlbuRx™ 5 and 25
- Albuminar® 5 and 25
- Beriplex® P/N
- Haemocomplettan® P
- Human-Albumin 20% Behring
- Inhibitors
- Berinert® P
- Kybernin® P
- Cardiology
- Streptase®
Alpha 1-Proteinase Inhibitor Deficiency
For people at risk from life-shortening emphysema through a genetic deficiency in their synthesis of this protein
- Zemaira®
Wound Healing
Wound healing therapies are used to facilitate healing
- Beriplast® P
- Fibrogammin® P
Immune Disorders and Immune Therapy
Immunoglobulins are used to treat infections and autoimmune diseases, and to prevent haemolytic disease in the newborn
- Polyvalent Immunoglobulins
- Beriglobin® P
- Carimune® NF
- Sandoglobulin
- Gamma-Venin® P
- Gammar® - P.I.V.
- Redimune®
- Venimmun® N
- Specific Immunoglobulins
- Berirab® P
- Hepatitis B Immunoglobulin P
- Rhesogamma® P
- Tetagam® P
- Varicellon® P
Back | Next |
